Merck’s MRK stock has risen 32.3% in the past three months. The stock has also been trading above its 50-day and 200-day ...

Spherix Global Insights reports new findings from its inaugural Market Dynamix(TM): PD-1 Inhibition in Solid Tumors (US) study, based on quantitative and qualitative responses from more than 100 U.S.

A recent Financial Times report stated that Merck MRK is in talks to buy Redwood City, CA-based cancer biotech, Revolution ...

Breakthrough Therapy Designation granted to zoldonrasib for the treatment of adult patients with KRAS G12D-mutated locally advanced or metastatic ...

For about seven minutes, we had some standard issue if not low scoring basketball at the Kohl Center on Saturday. A layup from Chase Ross pulled Marquette within one, 6-5. And then Wisconsin scored 10 ...

With both a label expansion and a conversion to a full approval, Eli Lilly has earned the FDA’s go-ahead to act on the initial promise it saw with its BTK inhibitor Jaypirca (pirtobrutinib). Just ...

Syracuse, N.Y. — The New York State Public High School Athletic Association (NYSPHSAA) on Tuesday approved a proposal that would set up a statewide, standardized process for classifying non-public ...

Introduction: There is an unmet need for therapeutics with a novel mechanism to address Q9 symptoms associated with conditions where aberrant glutamatergic neurotransmission is presumed pathogenic.

IDEAYA Biosciences Announces First-Patient-In for Phase 1/2 Combination Trial of IDE397, A Potential First-in-Class MAT2A Inhibitor, and Trodelvy® in MTAP-Deletion Non-Small Cell Lung Cancer PR ...

We’ve all heard the saying: “A little competition never hurt anyone.” In fact, you likely see a touch of competitiveness in just about everyone, including yourself. But how does competitiveness apply ...